艾灸治疗慢性病系统评价的报告与方法学质量评估
该研究检索六个数据库,纳入200篇艾灸治疗慢性病的系统评价,分别用PRISMA 2020和AMSTAR 2评估报告与方法学质量。PRISMA 2020报告中位得分为58.33,AMSTAR 2方法学中位得分为40.63,方法学质量仍不理想。有资金支持、英文发表、方案注册、应用PRISMA指南及进行GRADE评价的系统评价得分较高。
要点
- 艾灸慢性病系统评价的报告质量随时间总体改善,但方法学质量仍不理想。
- 开展GRADE证据质量评价对提升报告与方法学质量至关重要。
- 建议PRISMA 2020和AMSTAR 2制定艾灸专属扩展以更好指导报告与方法学。
核心结论
- 艾灸治疗慢性病系统评价的报告质量总体改善,但方法学质量仍不令人满意。
- 进行GRADE证据质量评价对提高报告和方法学质量至关重要。
研究设计与样本
- 检索六个数据库识别艾灸治疗慢性病的系统评价,最终纳入200篇系统评价。
- 分别基于PRISMA 2020声明和AMSTAR 2标准评估报告质量和方法学质量,并用单因素和多因素分析探索影响因素。
主要发现
- 基于PRISMA 2020评估的报告质量中位得分为58.33。
- 基于AMSTAR 2评估的方法学质量中位得分为40.63。
- 报告不完整涉及检索策略、对缺失信息的假设以及合成和展示结果的方法。
- 方法学不达标包括缺乏预设方案、缺乏对偏倚风险影响的分析以及缺乏资金来源报告。
- PRISMA 2020和AMSTAR 2得分较高的系统评价特征主要包括资金支持、英文发表、方案注册、应用PRISMA指南以及进行GRADE评价。
关键数值与推荐
- PRISMA 2020报告中位得分为58.33。
- AMSTAR 2方法学中位得分为40.63。
临床怎么用
- 开展艾灸慢性病系统评价时应进行GRADE证据质量评价以提升报告与方法学质量。
- 应关注方案注册、应用PRISMA指南并完整报告检索策略、缺失信息假设及资金来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Moxibustion is a simple and low-cost technique for chronic diseases. This study aimed to evaluate the quality of reports and methodologies of systematic reviews (SRs) related to the treatment of chronic diseases with moxibustion. METHODS: Six databases were searched to identify moxibustion SRs for the treatment of chronic diseases. The reporting and methodological quality were evaluated based on the PRISMA 2020 statement and AMSTAR 2 standard, respectively. Univariate and multivariate analyses were used to explore impact factors. RESULTS: A total of 200 SRs were included. The median reporting quality score based on the PRISMA 2020 evaluation was 58.33. The incomplete reports involved search strategies, assumptions about missing information, and methods to synthesize and display results. The median methodological quality score of AMSTAR 2 was 40.63. The substandard methodologies included lack of a prespecified protocol, analyses for impacts of the risk of bias, and reports of funding sources. The characteristics of SRs with higher PRISMA 2020 and AMSTAR 2 scores mainly included funding support, English publications, protocol registration, application of PRISMA guidelines, and conduct of GRADE evaluation. CONCLUSION: Over time, the reporting quality of SRs of moxibustion for chronic diseases has generally improved, but the methodological quality remains unsatisfactory. Conducting a GRADE evidence quality evaluation is crucial for improving the reporting and methodological quality. In the future, it is necessary for both PRISMA 2020 and AMSATR 2 to develop specific extensions for moxibustion to better guide the reporting and methodology of moxibustion SRs. STUDY REGISTRATION: PROSPERO ID CRD42020149024.
引用
- Chen R, Zhou X, Deng G, et al. Assessment of quality of reporting and methodology in systematic reviews of moxibustion for chronic diseases using PRISMA 2020 and AMSTAR 2. Complement Ther Med. 2025. PMID: 40381744. doi:10.1016/j.ctim.2025.103193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。